Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sequent Medical Inc.

Division of Terumo Corp.

Latest From Sequent Medical Inc.

Smaller But Eye-Catching Medtech Deals

Not all of the key medtech deals of 2016 were blockbusters. Herein are some of the more interesting smaller deals of the year.

Medical Device

Deals In Depth: June/July 2016

Celgene and Novartis each signed $3 billion immuno-oncology deals, with Jounce and Xencor, respectively; Galenica Group made a $1.5 billion acquisition for a hyperkalaemia drug. Public financings grew from May to July in the biopharma industry, but decreased month over month in the device sector.

Deals BioPharmaceutical

Deals Shaping The Medical Industry, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.

BioPharmaceutical Deals

Terumo Makes Big Bet On Aneurysm Embolization With Sequent Acquisition

Terumo will pay up to $380m for privately-held Sequent Medical to and improve its presence in the US neurovascular device market with Sequent’s WEB embolization system for treatment of wide-neck bifurcation intracranial aneurysms, the Japanese medtech giant announced on June 16.

Medical Device Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Terumo Corp.
  • Senior Management
  • Thomas Wilder, Pres. & CEO
    Kevin J Cousins, VP, CFO
    William R Patterson, PhD, VP, R&D & Operations
    Andrew J Hykes, VP, Commercial Operations
    Amy L Walters , VP, Clinical & Reg. Affairs
  • Contact Info
  • Sequent Medical Inc.
    Phone: (949) 830-9600
    11 Columbia
    Aliso Viejo, CA 92656